JWT wins more J&J trust

Australia - Johnson & Johnson has placed four more J&J brands into JWT Sydney's care - the business is believed to be worth in excess of AUD$5 million (S$6,403,417).

JWT will handle the brands Sudafed, Mylanta, Benadryl and Zyrtec with effect from this month. Existing J&J brands under their wing are Listerine, Visine, Reach, Band Aid, Purell and Diflucan.

"Our relationship with J&J goes from strength to strength and to have these four leading brands aligned to us is testament to that. We are thrilled to have these brands in our portfolio and look forward to starting work soon," Noel Magnus, CEO of JWT Australia & New Zealand, said.